The effectiveness of COVID-19 vaccine booster doses dropped well under 50 percent after four months against subvariants of the virus that causes COVID-19, according to a new study from the U.S. Centers for Disease Control and Prevention (CDC).
"Company to be able to perform approximately 30,000 tests a week by the end of July, supplementing public health response," according to a press release.
Pfizer has already profited billions of dollars from the COVID-19 pandemic, and it plans to do so for years to come via annual vaccinations and sales of its antiviral pill Paxlovid.
Health officials across 33 countries have received reports of 920 probable cases of severe acute hepatitis of unknown origin in young children, according to...